Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
We have isolated Xenopus p28Kix1, a member of the p21CIP1/p27KIP1/p57KIP2 family of cyclin-dependent kinase (Cdk) inhibitors. Members of this family negatively regulate cell cycle progression in mammalian cells by inhibiting the activities of Cdks. p28 shows significant sequence homology with p21, p27, and p57 in its N-terminal region, where the Cdk inhibition domain is known to reside. In contrast, the C-terminal domain of p28 is distinct from that of p21, p27, and p57. In co-immunoprecipitation experiments, p28 was found to be associated with Cdk2, cyclin E, and cyclin A, but not the Cdc2/cyclin B complex in Xenopus egg extracts. Xenopus p28 associates with the proliferating cell nuclear antigen, but with a substantially lower affinity than human p21. In kinase assays with recombinant Cdks, p28 inhibits pre-activated Cdk2/cyclin E and Cdk2/cyclin A, but not Cdc2/cyclin B. However, at high concentrations, p28 does prevent the activation of Cdc2/cyclin B by the Cdk-activating kinase. Consistent with the role of p28 as a Cdk inhibitor, recombinant p28 elicits an inhibition of both DNA replication and mitosis upon addition to egg extracts, indicating that it can regulate multiple cell cycle transitions. The level of p28 protein shows a dramatic developmental profile: it is low in Xenopus oocytes, eggs, and embryos up to stage 11, but increases approximately 100-fold between stages 12 and 13, and remains high thereafter. The induction of p28 expression temporally coincides with late gastrulation. Thus, although p28 may play only a limited role during the early embryonic cleavages, it may function later in development to establish a somatic type of cell cycle. Taken together, our results indicate that Xenopus p28 is a new member of the p21/p27/p57 class of Cdk inhibitors, and that it may play a role in developmental processes.
Aprelikova,
Both p16 and p21 families of cyclin-dependent kinase (CDK) inhibitors block the phosphorylation of cyclin-dependent kinases by the CDK-activating kinase.
1995, Pubmed
Aprelikova,
Both p16 and p21 families of cyclin-dependent kinase (CDK) inhibitors block the phosphorylation of cyclin-dependent kinases by the CDK-activating kinase.
1995,
Pubmed
Chan,
Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16ink4.
1995,
Pubmed
Chen,
Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA.
1995,
Pubmed
,
Xenbase
Chitnis,
Primary neurogenesis in Xenopus embryos regulated by a homologue of the Drosophila neurogenic gene Delta.
1995,
Pubmed
,
Xenbase
Coleman,
Negative regulation of the wee1 protein kinase by direct action of the nim1/cdr1 mitotic inducer.
1993,
Pubmed
Cyert,
Regulation of MPF activity in vitro.
1988,
Pubmed
,
Xenbase
Dasso,
Completion of DNA replication is monitored by a feedback system that controls the initiation of mitosis in vitro: studies in Xenopus.
1990,
Pubmed
,
Xenbase
Deng,
Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control.
1995,
Pubmed
Desai,
Activation of human cyclin-dependent kinases in vitro.
1992,
Pubmed
Dingwall,
Nuclear targeting sequences--a consensus?
1991,
Pubmed
Draetta,
Cdc2 activation: the interplay of cyclin binding and Thr161 phosphorylation.
1993,
Pubmed
Dunphy,
Fission yeast p13 blocks mitotic activation and tyrosine dephosphorylation of the Xenopus cdc2 protein kinase.
1989,
Pubmed
,
Xenbase
Elledge,
Cdk inhibitors: on the threshold of checkpoints and development.
1994,
Pubmed
Fangman,
A question of time: replication origins of eukaryotic chromosomes.
1992,
Pubmed
Gu,
Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit.
1993,
Pubmed
Guan,
Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function.
1994,
Pubmed
Halevy,
Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD.
1995,
Pubmed
Hannon,
p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest.
1994,
Pubmed
Harper,
Inhibition of cyclin-dependent kinases by p21.
1995,
Pubmed
Harper,
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
1993,
Pubmed
Hartenstein,
Early neurogenesis in Xenopus: the spatio-temporal pattern of proliferation and cell lineages in the embryonic spinal cord.
1989,
Pubmed
,
Xenbase
Howe,
Identification of a developmental timer regulating the stability of embryonic cyclin A and a new somatic A-type cyclin at gastrulation.
1995,
Pubmed
,
Xenbase
Jackson,
Early events in DNA replication require cyclin E and are blocked by p21CIP1.
1995,
Pubmed
,
Xenbase
Kato,
Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation.
1994,
Pubmed
Koff,
Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle.
1992,
Pubmed
Kumagai,
Control of the Cdc2/cyclin B complex in Xenopus egg extracts arrested at a G2/M checkpoint with DNA synthesis inhibitors.
1995,
Pubmed
,
Xenbase
Kumagai,
The cdc25 protein controls tyrosine dephosphorylation of the cdc2 protein in a cell-free system.
1991,
Pubmed
,
Xenbase
Lee,
Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution.
1995,
Pubmed
Leno,
DNA replication in cell-free extracts from Xenopus laevis.
1991,
Pubmed
,
Xenbase
Li,
Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair.
1994,
Pubmed
Luo,
Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1.
1995,
Pubmed
Massagué,
Mammalian antiproliferative signals and their targets.
1995,
Pubmed
Matsuoka,
p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene.
1995,
Pubmed
Minshull,
A MAP kinase-dependent spindle assembly checkpoint in Xenopus egg extracts.
1994,
Pubmed
,
Xenbase
Mueller,
Cell cycle regulation of a Xenopus Wee1-like kinase.
1995,
Pubmed
,
Xenbase
Murray,
Cell cycle extracts.
1991,
Pubmed
Newport,
A major developmental transition in early Xenopus embryos: I. characterization and timing of cellular changes at the midblastula stage.
1982,
Pubmed
,
Xenbase
Newport,
A major developmental transition in early Xenopus embryos: II. Control of the onset of transcription.
1982,
Pubmed
,
Xenbase
Noda,
Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen.
1994,
Pubmed
Nourse,
Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin.
1994,
Pubmed
Pagano,
Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27.
1995,
Pubmed
Parker,
p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells.
1995,
Pubmed
Polyak,
p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.
1994,
Pubmed
Polyak,
Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals.
1994,
Pubmed
Rempel,
Maternal Xenopus Cdk2-cyclin E complexes function during meiotic and early embryonic cell cycles that lack a G1 phase.
1995,
Pubmed
,
Xenbase
Serrano,
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
1993,
Pubmed
Sherr,
Mammalian G1 cyclins.
1993,
Pubmed
Smith,
Xenopus cell lines.
1991,
Pubmed
,
Xenbase
Su,
Cloning and characterization of the Xenopus cyclin-dependent kinase inhibitor p27XIC1.
1995,
Pubmed
,
Xenbase
Tang,
Two distinct mechanisms for negative regulation of the Wee1 protein kinase.
1993,
Pubmed
,
Xenbase
Toyoshima,
p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.
1994,
Pubmed
Waga,
The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA.
1994,
Pubmed
Warbrick,
A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen.
1995,
Pubmed
Xiong,
p21 is a universal inhibitor of cyclin kinases.
1993,
Pubmed
Yan,
An analysis of the regulation of DNA synthesis by cdk2, Cip1, and licensing factor.
1995,
Pubmed
,
Xenbase
Zhang,
p21-containing cyclin kinases exist in both active and inactive states.
1994,
Pubmed
el-Deiry,
WAF1, a potential mediator of p53 tumor suppression.
1993,
Pubmed
